Amaç: İleri evre serviks kanserli hastalarda eşzamanlı radyokemoterapiye bağlı erken ve geç yan etkilerin objektif olarak analizidir. Materyal ve Metot: Mayıs 2000-Şubat 2004 tarihleri arasında ileri evre serviks kanseri tanısı alan 24 olgu değerlendirildi. Medyan yaş 57 (aralık, 35-72), biyopsi sonrası 20 (83%) olgu epidermoid karsinom idi. Olguların FİGO sistemine göre dağılımları; 18 hasta (75%) evre IIb, 4 (17%) hasta evre IIIb, ve 2 (8%) hasta evre IVa idi. Medyan tümör çapı 5 cm (aralık, 1.9-8cm) olup, hastaların yarısında pelvik lenf nodu radyolojik olarak pozitif idi. Para-aortik lenf nodu tutulumu ve performans durumu ECOG > 2 olan hastalar bu protokole dahil edilmediler. Tüm pelvise 4-alan kutu tekniği ile Kobalt 60 veya Linak şartlarında medyan 50.4Gy (aralık, 45-50.4Gy) eksternal radyoterapi (RT) ve HDR Ir-192 ile 20Gy brakiterapi uygulandı. Sisplatin 40mg/m2/haftalık toplam 6 kür olarak planlandı. Erken yan etkiler NCI - CTC Version 2.0 ile tedavi esnasında, geç yan etkiler ise LENT / SOMA skalası ile tedaviden en az 90 gün sonra değerlendirildi. Seksüel disfonksiyon sadece objektif verilere göre değerlendirildi. Bulgular: Tüm RT süresi 10 hafta olup, hastaların hepsinde eksternal RT medyan 47 günde tamamlanmıştır. Oniki hasta (%50) planlanan 6 kür kemoterapiyi tam dozunda alırken, grubun diğer yarısı grad III-IV miyelosupresyon nedeniyle sadece 4 kür kemoterapi alabilmiştir. Erken veya geç grad III-IV gastrointestinal yan etki saptanmamış, ancak medyan 19 aylık takipte hastaların %58inde hayat kalitesini etkileyen grad III-IV seksüel disfonksiyon tespit edilmiştir. Sonuç: Erken hematolojik yan etkiler nedeniyle eşzamanlı radyokemoterapi yapılan hastalarda yakın takip gerekmektedir. Uzun sağkalım gösteren hastalarda ise seksüel disfonksiyon hayat kalitesini etkileyen önemli bir problemdir.
Purpose: To assess objectively the early and late effects of concomittant radiochemotherapy on patients with locally advanced cervical carcinoma. Materials and Methods: Twenty-four patients with locally advanced cervical carcinoma diagnosis were assessed between May 2000 - February 2004. Median age was 57 years (range 35- 72), and 20 (83%) patients were epidermoid carcinoma. According to the stages, 18 patients (75%) were FIGO IIb, 4 (17%) were IIIb, and 2 (8%) were IVa. Median tumor size was 5 cm (range, 1.9 - 8 cm), and half of the patients had radiologically positive pelvic lymph nodes. Patients who had positive para-aortic lymph nodes and ECOG performance status > 2 were excluded from the protocol. External radiotherapy (RT) was delivered to whole pelvis with a median dose of 50.4Gy/28fr (range, 45- 50.4Gy) using a box technique under Cobalt-60 or Linac conditions. HDR Ir-192 brachytherapy with a median dose of 20Gy/3- 4fr was delivered after completion of external RT. Cisplatinum administration with 40mg/m2/once weekly for 6 weeks was planned. Early effects were assessed with NCI-CTC Version 2.0 during treatment, late effects were assessed with LENT/SOMA scales minimum 90 days after completion of treatment. Sexual dysfunction was assessed only according to objective data. Results: Total radiotherapy time was 10 weeks, and external RT was completed in 47 days in all patients. Twelve patients (50%) completed their 6 cycles chemotherapy, where the other half of the patients completed only 4 cycles of chemotherapy because of grade III-IV myelosupression. Early or late grade III-IV gastrointestinal effects were not detected, grade III-IV sexual dysfunction which affected quality of life and sexual life was detected in %58 of patients in a median 19 months follow-up. Conclusion: Close follow-up is necessary in patients who received concomittant radiochemotherapy due to early hematologic side effects. In the long-term surviving patients, sexual dysfunction is a major problem which affected quality of life.
Other ID | JA23TR23KR |
---|---|
Journal Section | Research Article |
Authors | |
Publication Date | July 1, 2004 |
Submission Date | July 1, 2004 |
Published in Issue | Year 2004 Volume: 7 Issue: 3 |